Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Published Erratum
. 2022 Oct;24(10):2208.
doi: 10.1016/j.gim.2022.08.005.

Risks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared with those harboring protein truncating variants

Hongyan Li, Christoph Engel, Miguel de la Hoya, Paolo Peterlongo, Drakoulis Yannoukakos, Luca Livraghi, Paolo Radice, Mads Thomassen, Thomas V O Hansen, Anne-Marie Gerdes, Henriette R Nielsen, Sandrine M Caputo, Alberto Zambelli, Ake Borg, Angela Solano, Abigail Thomas, Michael T Parsons, Antonis C Antoniou, Goska Leslie, Xin Yang, Georgia Chenevix-Trench, Trinidad Caldes, Ava Kwong, Inge Søkilde Pedersen, Charlotte K Lautrup, Esther M John, Mary Beth Terry, John L Hopper, Melissa C Southey, Irene L Andrulis, Marc Tischkowitz, Ramunas Janavicius, Susanne E Boonen, Lone Kroeldrup, Liliana Varesco, Ute Hamann, Ana Vega, Edenir I Palmero, Judy Garber, Marco Montagna, Christi J Van Asperen, Lenka Foretova, Mark H Greene, Tina Selkirk, Pal Moller, Amanda E Toland, Susan M Domchek, Paul A James, Heather Thorne, Diana M Eccles, Sarah M Nielsen, Siranoush Manoukian, Barbara Pasini, Maria A Caligo, Conxi Lazaro, Judy Kirk, Barbara Wappenschmidt, Amanda B Spurdle, Fergus J Couch, Rita Schmutzler, David E Goldgar; ENIGMA Consortium and CIMBA Consortium
Free article
Published Erratum

Risks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared with those harboring protein truncating variants

Hongyan Li et al. Genet Med. 2022 Oct.
Free article
No abstract available

PubMed Disclaimer

Erratum for

  • Risks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared with those harboring protein truncating variants.
    Li H, Engel C, de la Hoya M, Peterlongo P, Yannoukakos D, Livraghi L, Radice P, Thomassen M, Hansen TVO, Gerdes AM, Nielsen HR, Caputo SM, Zambelli A, Borg A, Solano A, Thomas A, Parsons MT, Antoniou AC, Leslie G, Yang X, Chenevix-Trench G, Caldes T, Kwong A, Pedersen IS, Lautrup CK, John EM, Terry MB, Hopper JL, Southey MC, Andrulis IL, Tischkowitz M, Janavicius R, Boonen SE, Kroeldrup L, Varesco L, Hamann U, Vega A, Palmero EI, Garber J, Montagna M, Van Asperen CJ, Foretova L, Greene MH, Selkirk T, Moller P, Toland AE, Domchek SM, James PA, Thorne H, Eccles DM, Nielsen SM, Manoukian S, Pasini B, Caligo MA, Lazaro C, Kirk J, Wappenschmidt B, Spurdle AB, Couch FJ, Schmutzler R, Goldgar DE; ENIGMA Consortium; CIMBA Consortium. Li H, et al. Genet Med. 2022 Jan;24(1):119-129. doi: 10.1016/j.gim.2021.08.016. Epub 2021 Nov 30. Genet Med. 2022. PMID: 34906479 Free PMC article.

Publication types

LinkOut - more resources